Vivo Capital’s Clene CLNN Stock Holding History

Vivo Capital’s Portfolio CLNN Stock Details CLNN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-132,267	Closed	-$1.4M	–	51
2023 Q3	$1.4M	Sell	132,267 -93,764	-41%	-$1.3M	0.15%	45
2023 Q2	$3.71M	Buy	+226,031	New	+$4.41M	0.26%	39

Other funds holding CLNN

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LCM

Lunt Capital Management Holladay, Utah $260M AUM 10.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AWM

AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vivo Capital's CLNN Position: Q4 2023 in Review

Vivo Capital sold out of Clene (CLNN) in Q4 2023, closing a stake of 132,267 shares — an estimated $1.4M sold.

Vivo Capital first reported a position in CLNN in Q2 2023 and held it in 2 quarters. The position peaked at $3.71M in Q2 2023. 44 funds tracked by Wall St. Rank hold CLNN as of Q4 2023.

Vivo Capital reported no remaining Clene position as of Q4 2023 after selling out during the quarter.
Vivo Capital sold 132,267 Clene shares in Q4 2023, an estimated $1.4M.
Vivo Capital first reported a position in Clene in Q2 2023 and held it in 2 quarters.
Vivo Capital's Clene position peaked at $3.71M in Q2 2023.
44 funds tracked by Wall St. Rank held Clene as of Q4 2023.

Based on Vivo Capital's 13F filing for Q4 2023, filed 7 Feb 2024.